The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast‐ovarian cancer
Open accessAbstract
BACKGROUND: In women at increased risk for breast and ovarian cancer, the identification of a mutation in breast cancer gene 1 (BRCA1) and BRCA2 has important implications for screening and prevention counseling. Uncertainty regarding the role of BRCA1 and BRCA2 testing in high‐risk women from diverse ancestral backgrounds exists because of variability in prevalence estimates of deleterious (disease‐associated) mutations in non‐white populations. In this study, the authors examined the prevalence of BRCA1 and BRCA2 mutations in an ethnically diverse group of women who were referred for genetic testing. METHODS: In this cross‐sectional analysis, the prevalence of BRCA1 and BRCA2 mutations was assessed in a group of non‐Ashkenazi Jewish women who underwent genetic testing. RESULTS: From 1996 to 2006, 46,276 women who met study criteria underwent DNA full‐sequence analysis of the BRCA1 and BRCA2 genes. Deleterious mutations were identified in 12.5% of women, and recurrent deleterious mutations (prevalence >2%) were identified in all ancestral groups. Women of non‐European descent were younger (mean age, 45.9 years; standard deviation [SD], 11.6 years) than European women (mean age, 50 years; SD, 11.9 years; P < .001). Women of African (15.6%; odds ratio [OR], 1.3 [95% confidence interval (95% CI), 1.1‐1.5]) and Latin American (14.8%; OR, 1.2 [95% CI, 1.1‐1.4]) ancestries had a significantly higher prevalence of deleterious BRCA1 and BRCA2 mutations compared with women of Western European ancestry (12.1%), primarily because of an increased prevalence of BRCA1 mutations in those 2 groups. Non‐European ethnicity was associated strongly with having a variant of uncertain significance; however, reclassification decreased variant reporting (from 12.8%→5.9%), and women of African ancestry experienced the largest decline (58%). CONCLUSIONS: Mutation prevalence was found to be high among women who were referred for clinical BRCA1 and BRCA2 testing, and the risk was similar across diverse ethnicities. BRCA1 and BRCA2 testing is integral to cancer risk assessment in all high‐risk women. Cancer 2009. © 2009 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of Overweight and Obesity in the United States, 1999-2004
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006) · JAMA · doi:10.1001/jama.295.13.1549 · Cited by 8,720
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
Self-citationPrevalence of Overweight and Obesity in the United States
Crespo, C. J., & Ellen, S. (2003) · Obesity: Etiology Assessment Treatment and Prevention · doi:10.5040/9781718206601.ch-001 · Cited by 4,379
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews
Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., & Tucker, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362001 · Cited by 2,281
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
King, M.-C., Marks, J. H., & Mandell, J. B. (2003) · Science · doi:10.1126/science.1088759 · Cited by 2,229
Risks of cancer in BRCA1-mutation carriers
FORD, D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91578-4 · Cited by 1,850
Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations
Rebbeck, T. R., Lynch, H. T., Neuhausen, S. L., Narod, S. A., van't Veer, L., Garber, J. E., Evans, G., Isaacs, C., Daly, M. B., Matloff, E., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012158 · Cited by 1,465
Rebbeck, T. R., Friebel, T., Lynch, H. T., Neuhausen, S. L., van ’t Veer, L., Garber, J. E., Evans, G. R., Narod, S. A., Isaacs, C., Matloff, E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.188 · Cited by 1,171
Triple negative tumours: a critical review
Reis‐Filho, J. S., & Tutt, A. N. J. (2008) · Histopathology · doi:10.1111/j.1365-2559.2007.02889.x · Cited by 884
Frank, T. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1480 · Cited by 812
The genetic attributable risk of breast and ovarian cancer
Claus, E. B., Schildkraut, J. M., Thompson, W. D., & Risch, N. J. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960601)77:11<2318::aid-cncr21>3.0.co;2-z · Cited by 744
Efficacy of Bilateral Prophylactic Mastectomy in BRCA1 and BRCA2 Gene Mutation Carriers
Hartmann, L. C., Sellers, T. A., Schaid, D. J., Frank, T. S., Soderberg, C. L., Sitta, D. L., Frost, M. H., Grant, C. S., Donohue, J. H., Woods, J. E., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.21.1633 · Cited by 743
Self-citationTrends in Breast Cancer by Race and Ethnicity: Update 2006
Smigal, C., Jemal, A., Ward, E., Cokkinides, V., Smith, R., Howe, H. L., & Thun, M. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.3.168 · Cited by 704
Hereditary Cancer Predisposition Syndromes
Garber, J. E., & Offit, K. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.042 · Cited by 697
Ethnicity and Breast Cancer: Factors Influencing Differences in Incidence and Outcome
Chlebowski, R. T., Chen, Z., Anderson, G. L., Rohan, T., Aragaki, A., Lane, D., Dolan, N. C., Paskett, E. D., McTiernan, A., Hubbell, F. A., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji064 · Cited by 656
Contralateral Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
Metcalfe, K., Lynch, H. T., Ghadirian, P., Tung, N., Olivotto, I., Warner, E., Olopade, O. I., Eisen, A., Weber, B., McLennan, J., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.033 · Cited by 621
Morris, G. J., Naidu, S., Topham, A. K., Guiles, F., Xu, Y., McCue, P., Schwartz, G. F., Park, P. K., Rosenberg, A. L., Brill, K., et al. (2007) · Cancer · doi:10.1002/cncr.22836 · Cited by 602
Frank, T. S., Deffenbaugh, A. M., Reid, J. E., Hulick, M., Ward, B. E., Lingenfelter, B., Gumpper, K. L., Scholl, T., Tavtigian, S. V., Pruss, D. R., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.6.1480 · Cited by 558
Self-citationPopulation genetics of BRCA1 and BRCA2.
Szabo, C. I., & King, M. (1997) · Europe PMC (PubMed Central) · Cited by 500
Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1
Verhoog, L., Brekelmans, C., Seynaeve, C., van den Bosch, L., Dahmen, G., van Geel, A., Tilanus-Linthorst, M., Bartels, C., Wagner, A., van den Ouweland, A., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07065-7 · Cited by 452
Trends in Breast Cancer by Race and Ethnicity
Ghafoor, A., Jemal, A., Ward, E., Cokkinides, V., Smith, R., & Thun, M. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.6.342 · Cited by 451
Eisen, A., Lubinski, J., Klijn, J., Moller, P., Lynch, H. T., Offit, K., Weber, B., Rebbeck, T., Neuhausen, S. L., Ghadirian, P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.7138 · Cited by 443
Armstrong, K. (2005) · JAMA · doi:10.1001/jama.293.14.1729 · Cited by 432
Goldgar, D. E., Easton, D. F., Deffenbaugh, A. M., Monteiro, A. N. A., Tavtigian, S. V., & Couch, F. J. (2004) · The American Journal of Human Genetics · doi:10.1086/424388 · Cited by 391
Self-citationWhittemore, A. S., Gong, G. D., & Itnyre, J. (1997) · PubMed · Cited by 383
Oddoux, C., Struewing, J. P., Clayton, C. M., Neuhausen, S., Brody, L. C., Kaback, M., Haas, B., Norton, L., Borgen, P., Jhanwar, S., et al. (1996) · Nature Genetics · doi:10.1038/ng1096-188 · Cited by 381
Neuhausen, S. L., Godwin, A. K., Gershoni-Baruch, R., Schubert, E., Garber, J., Stoppa-Lyonnet, D., Olah, E., Csokay, B., Serova, O., Lalloo, F., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301885 · Cited by 335
Prevalence of Pathogenic BRCA1 Mutation Carriers in 5 US Racial/Ethnic Groups
John, E. M., Miron, A., Gong, G., Phipps, A. I., Felberg, A., Li, F. P., West, D. W., & Whittemore, A. S. (2007) · JAMA · doi:10.1001/jama.298.24.2869 · Cited by 327
A suggested nomenclature for designating mutations
Beaudet, A. L., & Tsui, L.-C. (1993) · Human Mutation · doi:10.1002/humu.1380020402 · Cited by 308
Nanda, R., Schumm, L. P., Cummings, S., Fackenthal, J. D., Sveen, L., Ademuyiwa, F., Cobleigh, M., Esserman, L., Lindor, N. M., Neuhausen, S. L., et al. (2005) · JAMA · doi:10.1001/jama.294.15.1925 · Cited by 250
Breast cancer genetics in African Americans
Olopade, O. I., Fackenthal, J. D., Dunston, G., Tainsky, M. A., Collins, F., & Whitfield-Broome, C. (2003) · Cancer · doi:10.1002/cncr.11019 · Cited by 175
John, E. M., Horn‐Ross, P. L., & Koo, J. (2003) · PubMed · Cited by 158
Murtaugh, M. A., Sweeney, C., Giuliano, A. R., Herrick, J. S., Hines, L. M., Byers, T., Baumgartner, K. B., & Slattery, M. L. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.4.978 · Cited by 157
Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2
Liede, A., & Narod, S. (2002) · Human Mutation · doi:10.1002/humu.10154 · Cited by 148
Lerman, C., Hughes, C., Benkendorf, J., Biesecker, B. B., Kerner, J. F., Willison, J., Eads, N. L., Hadley, D. W., & Lynch, J. W. (1999) · PubMed · Cited by 140
The Association between Race and Attitudes about Predictive Genetic Testing
Peters, N., Rose, A., & Armstrong, K. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.361.13.3 · Cited by 139
Slattery, M. L., Sweeney, C., Edwards, S. L., Herrick, J. S., Baumgartner, K. B., Wolff, R. K., Murtaugh, M. A., Baumgartner, R., Giuliano, A. R., & Byers, T. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9292-y · Cited by 136
Racial differences in premenopausal endogenous hormones
Pinheiro, S. P., Holmes, M. D., Pollak, M. N., Barbieri, R. L., & Hankinson, S. E. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0944 · Cited by 119
Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers
Rebbeck, T. R. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00269-1 · Cited by 95
Racial/Ethnic Differences in Postmenopausal Endogenous Hormones: The Multiethnic Cohort Study
Setiawan, V. W., Haiman, C. A., Stanczyk, F. Z., Marchand, L. L., & Henderson, B. E. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0307 · Cited by 84
Hausauer, A. K., Keegan, T. H. M., Chang, E. T., & Clarke, C. A. (2007) · Breast Cancer Research · doi:10.1186/bcr1839 · Cited by 82
Wideroff, L., Vadaparampil, S. T., Breen, N., Croyle, R. T., & Freedman, A. N. (2003) · Public Health Genomics · doi:10.1159/000078162 · Cited by 82
Haffty, B., Silber, A., Matloff, E., Chung, J. Y., & Lannin, D. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.034744 · Cited by 74
Evaluation of models to predict BRCA germline mutations
kConFab Investigators, Kang, H. H., Williams, R., Leary, J., Ringland, C. L., Kirk, J., & Ward, R. L. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603358 · Cited by 64
Judkins, T., Hendrickson, B. C., Deffenbaugh, A. M., Eliason, K., Leclair, B., Norton, M. J., Ward, B. E., Pruss, D., & Scholl, T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1241 · Cited by 62
Self-citationHendrickson, B. C., Judkins, T., Ward, B. D., et al. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20189 · Cited by 56
Self-citationGenetic Testing of African Americans for Susceptibility to Inherited Cancers
Matthews, A. K., Cummings, S. A., Thompson, S. S., Wohl, V., List, M. A., & Olopade, O. I. (2000) · Journal of Psychosocial Oncology · doi:10.1300/j077v18n02_01 · Cited by 53
Social disparities in cancer: lessons from a multidisciplinary workshop
Weissman, J. S., & Schneider, E. C. (2005) · Cancer Causes & Control · doi:10.1007/s10552-004-1255-1 · Cited by 33
Judkins, T., Hendrickson, B. C., Deffenbaugh, A. M., & Scholl, T. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.07.024 · Cited by 32
Self-citationDiet and breast carcinoma in multiethnic populations
Wu, A. H. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000301)88:5+<1239::aid-cncr10>3.0.co;2-5 · Cited by 24
Genetics in Clinical Cancer Care: A Promise Unfulfilled among Minority Populations
Olopade, O. I. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.1683.13.11 · Cited by 23
Prophylactic Mastectomy: Obstacles and Benefits
Lynch, H. T., Lynch, J. F., & Rubinstein, W. S. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.21.1586 · Cited by 21
Cited by
Cancer health disparities in racial/ethnic minorities in the United States
Zavala, V. A., Bracci, P. M., Carethers, J. M., Carvajal-Carmona, L., Coggins, N. B., Cruz-Correa, M. R., Davis, M., de Smith, A. J., Dutil, J., Figueiredo, J. C., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01038-6 · Cited by 912
PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
Rose, M., Burgess, J. T., O’Byrne, K., Richard, D. J., & Bolderson, E. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.564601 · Cited by 719
Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment
Kurian, A. W., Hare, E. E., Mills, M. A., Kingham, K. E., McPherson, L., Whittemore, A. S., McGuire, V., Ladabaum, U., Kobayashi, Y., Lincoln, S. E., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.6607 · Cited by 485
Kurian, A. W., Ward, K. C., Howlader, N., Deapen, D., Hamilton, A. S., Mariotto, A., Miller, D., Penberthy, L. S., & Katz, S. J. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01854 · Cited by 387
Cragun, D., Weidner, A., Lewis, C., Bonner, D., Kim, J., Vadaparampil, S. T., & Pal, T. (2017) · Cancer · doi:10.1002/cncr.30621 · Cited by 293
Metadata
- Authors
- Hall, M. J., Reid, J. E., Burbidge, L. A., Pruss, D., Deffenbaugh, A. M., Frye, C., Wenstrup, R. J., Ward, B. E., Scholl, T. A., & Noll, W. W.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2009-04-28
- Volume
- 115
- Issue
- 10
- Pages
- 2222-2233
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1983933332
- Cited by
- 365
- References
- 54
- FWCI
- 8.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.